Now that "oldwillie" has made peace with his buddy, we can get to the business of saving "flatrock" 20k. The building of a new plant in Nebraska likely makes as much sense as that testament to bureacracy they built in Franklin Lakes. It is all about Senior Management arrogance. They don't ever pay the price. The shareholders pay by having this no growth dog stuck at the same price it was 4 years ago.
Ask Kozy about the plant...he has been with BD forever. He will give you classic political "spin". Ask Cohen about no growth...you will get talk of futures...no execution. It took the new "bean counter" CEO a year to get his former boss off the Board. You know - the guy who has delivered nothing.
Senior Management at BD will continue to punish the many good people who want to do it well. It is just that - Management - not Leadership. And they keep a Board who protects them. Can anyone honestly challenge that.
Hey "flatrock" - $32 is no bargain. Better go elsewhere.
Fourramsfans, if you don't have anything constructive to say, keep your boring spelling lessons to yourself.
Anyway, I thought you had "strongly sold" therefore you don't have any business here.
In your very words: BETTER GO ELSEWHERE.
Thanks for the clarification. Your explanation rings true with me.
Whats the feeling within BD at the moment?
Is the CEO/President and new Chairman of the Board making a difference or is he just tightening the screws?
If BD decides to replace EL at the top I would suggest they look outside. The internal candidates are all weak IMHO and the performance of the firm under their collective leadership has been disappointing.
I would look seriously at a spin-out of BD Bioscience under Deb Neff when market conditions permit later this year, and a search for a new CEO to reinvigorate the medical device company that would remain. I would divest micro and be relatively price insensitive in so doing. I would consider other strategic options for BD Biosciences but not as a preference. I would also look seriously at developing strategic options for the medical device business as the rejuvenation of those businesses may not be forthcoming and its best role may be to provide positive cash flow to an enterprise in higher margin/growth businesses.
Just IMHO. I actually doubt they will do anything.......
Thank you for an exceptionally perceptive and literate posting. Your comments summarize the situation exactly. Wall Street analysts should read it, although I think most of them do understand and agree with all the points you make. I hope Ed Ludwig reads it.
Know4Not & King800m ,
I too agree with the assessment. I read the current situation as untenable. Something has to change. Would either of you care to speculate on the future? Will BDX grow, be acquired or slowly fade into oblivion?
Because of anti-trust problems I doubt that BDX will be acquired. However, if you carefully re-read Know4Not's comments it's clear that there eventually can be a happy ending here. That is through the spin-off of Biosciences and improvement in BDX's profit margins, particularly overseas, in my opinion. Given that happy scenario the Company will be able to buy back a significant amount of stock. All this depends on Ed Ludwig having the fire in his belly to shake things up and pursue shareholder value aggressively. I leave it to you insiders to assess the likelihood of that. As an outsider, I am skeptical.